Increased radiosensitivity of p16 gene-deleted human glioma cells after transfection with wild-type p16 gene.
The A1235 and T98 cell lines derived from human gliomas have homozygous deletions in their p16 genes and are radiosensitive and radioresistant, respectively, with respect to other established glioma cell lines. These differences in radiosensitivity may be due to variations to some extent among cell lines, rather than genetically defined resistance or sensitivity. We examined the effect on radiation sensitivity of introducing a wild-type p16 gene into both p16-deficient glioma cell lines. The plasmid pOPMTS containing human wild-type p16 cDNA and a neomycin resistance gene, or the control plasmid pOPRSV1, were transfected into these cells. Clones from both cell lines, which expressed wild-type p16 mRNA constitutively after transfection with pOPMTS, were more radiosensitive than the parental cells and clones obtained after transfection with the negative control plasmid.
Miyakoshi
J
J
Department of Radiation Genetics, Faculty of Medicine, Kyoto University, Sakyo-ku.
Kitagawa
K
K
Yamagishi
N
N
Ohtsu
S
S
Day
R S
RS
Takebe
H
H
D002352:Carrier Proteins / Q000235:genetics*; D019941:Cyclin-Dependent Kinase Inhibitor p16; D016147:Genes, Tumor Suppressor; D005910:Glioma / Q000235:genetics / Q000532:radiotherapy*; D006801:Humans; D012333:RNA, Messenger / Q000032:analysis; D011836:Radiation Tolerance; D014162:Transfection; D014407:Tumor Cells, Cultured
D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D012333:RNA, Messenger